peptides | pharmaphorum

Friday 22 November 2024

Channels

Content type

Categories

Categories

Sort by

Order

peptides

News

MBX joins IPO queue with $100m Nasdaq filing

MBX joins IPO queue with $100m Nasdaq filing

Further signs that the biotech initial public offering (IPO) market is picking up have come with a filing by MBX Biosciences, seeking around $100 million to take a hypoparathyroidism candid

News

GLP-1 bonanza spurs big investment at CDMO CordenPharma

GLP-1 bonanza spurs big investment at CDMO CordenPharma

CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.

News

University of Southampton scientist Prof Ali Tavassoli, who is Curve's chief scientific officer

UK biotech Curve swings £40.5m in Pfizer-backed round

Southampton, UK-based start-up Curve Therapeutics has completed a £40.5 million ($51 million) in Series A financing for its drug discovery platform that enables drug scree

R&D

Peptide Based Therapeutics Summit banner

Partner Content

The Brand-New Peptide Based Therapeutics Summit - Boston, MA

First event dedicated to designing, synthesising & identifying the optimal peptide-based drugs

News

Astellas

Astellas builds in protein degraders with PeptiDream deal

Astellas has made another move into the area of protein degrader drugs, announcing its second partnership in the category in the space of two months.

Partner Content

Controlled Release Delivery

Partner Content

Ipsen presents on oral peptides innovations, advances and de...

Ipsen presents on oral peptides innovations & delivery